RegInfo: The international database of regulated information of listed companies

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
- Remgro
- RICHEMONT
- RMB Holdings
- Sanlam
- Sasol
- Shoprite
- Standard Bank Group
- Tiger Brands
- Vodacom Group
- WOOLWORTHS
> TA 25
Israel - TA 25
- AVNER OIL
- AZRIELI GROUP
- BEZEQ
- DELEK DRILLIN
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- GAZIT GLOBE
- ICL
- IFF
- ISRAEL CORP
- KENON
- LEUMI
- MIGDAL INSURANCE
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- OSEM
- PAZ OIL
- PERRIGO
- POALIM
- STRAUSS GROUP
- TEVA

Europe

PERIODIC INFORMATION

ANNUAL FINANCIAL REPORT	HALF-YEAR FINANCIAL	QUARTERLY INFORMATION
WOOD & Company Installux Euromedis Groupe	Groupe Partouche Fayenceries de Sarreguemines Digoin et Vitry-le-Francois Tiger Brands	Groupe Flo S.A. NORSK HYDRO NORSK HYDRO
More documents (17652)	More documents (18945)	More documents (33660)
REGISTRATION DOCUMENT	20F	STATUTORY AUDITORS C
Ubisoft Entertainment Aurea Alstom	Chunghwa Telecom BRF SA United Microelectronics	CRCAM de Paris et d'Ile de France CRCAM de Paris et d'Ile de France Atos
More documents (5949)	More documents (467)	More documents (1734)
AGM	INTERNAL CONTROL	ANNUAL INFO MEMO ART
Installux IDI STENTYS	CRCAM Centre Loire Premia Foods ROCHE	SOFRAGI Exacompta Clairefontaine S.A. Société Générale
More documents (12064)	More documents (2236)	More documents (1324)

PERMANENT INFORMATION

2019.06.26 | 19:48 | Permanent Information Releases / Calendar

CHR. HANSEN

Changes to the financial calendar 2018/19 - HTML (w)

2019.06.26 | 19:30 | Permanent Information Releases / Sales and Revenues

CHR. HANSEN

Interim Report September 1, 2018 - May 31, 2019 - HTML (w)

2019.06.26 | 19:30 | Permanent Information Releases / General Company News

SANOFI-AVENTIS

Sanofi : La FDA approuve Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne - HTML (w)

2019.06.26 | 19:30 | Permanent Information Releases / General Company News

SANOFI-AVENTIS

Sanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis - HTML (w)

2019.06.26 | 19:15 | Permanent Information Releases / General Company News

AB SCIENCE

AB Science annonce les résultats de l'analyse intérimaire de l'étude AB09004 dans la maladie d'Alzheimer - HTML (w)

More documents (280108)

Financial transactions

2019.06.26 | 19:48 | Permanent Information Releases / Calendar

CHR. HANSEN

Changes to the financial calendar 2018/19 - HTML (w)

2019.06.26 | 19:30 | Permanent Information Releases / Sales and Revenues

CHR. HANSEN

Interim Report September 1, 2018 - May 31, 2019 - HTML (w)

2019.06.26 | 19:30 | Permanent Information Releases / General Company News

SANOFI-AVENTIS

Sanofi : La FDA approuve Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne - HTML (w)

2019.06.26 | 19:30 | Permanent Information Releases / General Company News

SANOFI-AVENTIS

Sanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis - HTML (w)

2019.06.26 | 19:15 | Permanent Information Releases / General Company News

AB SCIENCE

AB Science annonce les résultats de l'analyse intérimaire de l'étude AB09004 dans la maladie d'Alzheimer - HTML (w)

More documents (5466)